Correction to: J Pharm Policy Pract (2020) 13:18
https://doi.org/10.1186/s40545-020-00219-1
Following publication of the original article [1], we notified of a mistake in the article’s title.
Correct article title:
Amid COVID-19: the importance of developing a positive reporting culture of adverse drug reaction (ADR) and medical device incident (MDI) for Global Health and public safety
Reference
Elbeddini A, et al. Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract. 2020;13:18. https://doi.org/10.1186/s40545-020-00219-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Elbeddini, A., Yeats, A. & Lee, S. Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J of Pharm Policy and Pract 13, 30 (2020). https://doi.org/10.1186/s40545-020-00231-5
Published:
DOI: https://doi.org/10.1186/s40545-020-00231-5